NCT00986037View on ClinicalTrials.gov

Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2010

Conditions
Asthma
Interventions
DRUG

ABT-308

Single IV doses

DRUG

ABT-308

Multiple SC doses x 3

DRUG

Placebo

Single IV dose

DRUG

Placebo

Multiple SC doses x 3

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY